Insights
Search Results
Client Highlights
3.13.26
Wilson Sonsini Advises Urgently on Acquisition by Agero
On March 13, 2026, Agero, a software-enabled driver safety services and technology company, announced that it has entered into an agreement to acquire Urgent.ly (Urgently), a digital software platform that provides roadside and mobility assistance, for a cash price of $5.50 per share. The tender offer and merger are expected to close by the end of May 2026, subject to satisfaction of customary closing conditions. Wilson Sonsini Goodrich & Rosati advised Urgently on the transaction.
Client Highlights
12.15.25
Wilson Sonsini Advises Quantum Computing on $110 Million Acquisition of Luminar Semiconductor
On December 15, 2025, Quantum Computing (QCi), an innovative, quantum optics and integrated photonics technology company, announced that it has signed an agreement to acquire Luminar Semiconductor (LSI), a wholly owned subsidiary of Luminar Technologies, in an all-cash transaction valued at $110 million, subject to customary adjustments. Wilson Sonsini Goodrich & Rosati is advising QCi on the transaction
Client Highlights
10.20.25
Wilson Sonsini Advises Lexeo Therapeutics on $153.8 Million Underwritten Public Offering and Concurrent Private Placement
On October 20, 2025, Lexeo Therapeutics, a clinical-stage genetic medicine company dedicated to pioneering novel treatments for cardiovascular diseases, announced the closing of its previously announced underwritten public offering and concurrent private placement, for total gross proceeds to Lexeo of approximately $153.8 million, before deducting underwriting discounts and commissions and other expenses. Wilson Sonsini Goodrich & Rosati represented Lexeo in the transaction.
Client Highlights
6.02.25
Wilson Sonsini Advises Lexeo Therapeutics on $80 Million Private Placement Equity Financing
On May 28, 2025, Lexeo Therapeutics, a clinical-stage genetic medicine company dedicated to pioneering novel treatments for cardiovascular diseases, closed its previously announced $80 million private placement equity financing. Wilson Sonsini Goodrich & Rosati advised Lexeo on the transaction.
Client Highlights
2.28.25
Wilson Sonsini Advises Urgent.ly on Debt Restructuring and New $20 Million Revolving Credit Facility
On February 26, 2025, Urgent.ly, a U.S.-based leading provider of digital roadside and mobility assistance technology and services, announced that it reached an agreement with its lenders resulting in significant capital structure improvements. Urgent.ly entered into a new credit agreement for an asset-based revolving credit facility for up to $20 million with MidCap Financial, which will be used to repay existing indebtedness and to help the company advance its mission to transform the legacy roadside assistance market and to develop and define the new market for connected mobility assistance services for automotive, insurance, fleet, logistics, new mobility, and technology transportation companies.
Client Highlights
10.25.24
Wilson Sonsini Represents Squarespace Founder and CEO in Close of $7.2 Billion Take-Private Transaction
On October 17, 2024, global investment firm Permira announced the completion of its funds’ previously announced acquisition of Squarespace, Inc. in an all-cash transaction that valued Squarespace at an aggregated transaction value of approximately $7.2 billion. As part of the transaction, Squarespace founder and CEO Anthony Casalena rolled over a substantial majority of his existing equity and continues to be one of the largest shareholders in the company. He continues to serve as Squarespace’s CEO and board chairman, leading the business in all aspects of its operations, along with Squarespace’s current leadership team, who have continued in their roles.
Wilson Sonsini Goodrich & Rosati represented Mr. Casalena in the transaction. The firm’s team included Marty Korman, Todd Cleary, Megan Baier, Amy Simmerman, Catherine Riley Tzipori, Derek Wallace, Carole Rosenberg, Adrian Broderick, and Ryan Hart.
For more information, please see the companies’ joint news release.
Wilson Sonsini Goodrich & Rosati represented Mr. Casalena in the transaction. The firm’s team included Marty Korman, Todd Cleary, Megan Baier, Amy Simmerman, Catherine Riley Tzipori, Derek Wallace, Carole Rosenberg, Adrian Broderick, and Ryan Hart.
For more information, please see the companies’ joint news release.
Client Highlights
3.14.24
Wilson Sonsini Advises Lexeo on Oversubscribed $95 Million Equity Financing
On March 13, 2024, Lexeo Therapeutics, Inc., a clinical-stage genetic medicine company dedicated to pioneering treatments for genetically defined cardiovascular diseases and APOE4-associated Alzheimer’s disease, announced the closing of its previously announced private placement with total gross proceeds of approximately $95 million. The financing was co-led by Braidwell LP and Adage Capital Partners LP, with participation from new and existing investors including RA Capital Management, Surveyor Capital (a Citadel company), Eventide Asset Management, Novo Holdings A/S, Invus, Laurion Capital Management, Longitude Capital, Omega Funds, and Woodline Partners LP.
Client Highlights
5.30.23
Wilson Sonsini Advises Embark Technology on Acquisition by Applied Intuition
On May 25, 2023, Applied Intuition, Inc., a tooling and software provider for autonomous vehicle development, and Embark Technology, Inc., an autonomous trucking software company, announced that the companies have entered into a definitive merger agreement under which Applied will acquire Embark in an all-cash transaction in which Embark shareholders will receive $2.88 per share in cash. Wilson Sonsini Goodrich & Rosati is advising Embark and its Transaction Committee on the transaction.
Founded in 2016, Embark has built a robust autonomous software stack that uses machine learning methodologies for perception while relying on a safety-redundant compute system. Embark also developed a custom-built hardware platform optimized for autonomy and has performed extensive real-world testing and system deployment, with over 1.5 million miles of autonomous operations conducted on highways. Applied aims to integrate Embark's internal tools, data, and software assets to further improve its offerings for customers in the trucking and automotive industries.
The transaction, which has been approved unanimously by the boards of directors of both companies, is expected to close in Q3 2023 and is subject to approval by Embark shareholders and other customary closing conditions. Upon completion of the transaction, Embark shares and warrants will cease trading on NASDAQ, and Embark will become a privately held company.
The Wilson Sonsini team advising Embark and its Transaction Committee on the acquisition includes:
Founded in 2016, Embark has built a robust autonomous software stack that uses machine learning methodologies for perception while relying on a safety-redundant compute system. Embark also developed a custom-built hardware platform optimized for autonomy and has performed extensive real-world testing and system deployment, with over 1.5 million miles of autonomous operations conducted on highways. Applied aims to integrate Embark's internal tools, data, and software assets to further improve its offerings for customers in the trucking and automotive industries.
The transaction, which has been approved unanimously by the boards of directors of both companies, is expected to close in Q3 2023 and is subject to approval by Embark shareholders and other customary closing conditions. Upon completion of the transaction, Embark shares and warrants will cease trading on NASDAQ, and Embark will become a privately held company.
The Wilson Sonsini team advising Embark and its Transaction Committee on the acquisition includes:
Client Highlights
2.13.23
Wilson Sonsini Advises Urgent.ly on Merger with Otonomo Technologies
Urgent.ly, Inc. (Urgently), a U.S.-based leading provider of digital roadside and mobility assistance technology and services, and Otonomo Technologies Ltd., the platform powering the mobility economy, announced that they have entered into a definitive agreement to merge in an all-stock transaction.
Client Highlights
1.20.23
Wilson Sonsini Advises Welcome Homes on $29 Million Series A
On January 12, 2023, Welcome Homes, a New York City-based proptech company that delivers luxurious homes at a guaranteed price in just a few clicks, announced that it has raised more than $29 million in Series A funding, led by Era Ventures. The funding round also included participation from Parker89, Montage Ventures, Foundamental, Global Founders Capital, Activant Capital, Gaingels, Elefund, and Arkin Holdings. Wilson Sonsini Goodrich & Rosati advised Welcome Homes on the transaction.
Client Highlights
12.09.22
Firm Advises Arcellx on $4 Billion Collaboration with Kite
On December 9, 2022, clinical-stage biotechnology company Arcellx and Gilead-owned biopharmaceutical company Kite announced a global strategic collaboration to develop and commercialize Arcellx’s lead late-stage myeloma candidate. Wilson Sonsini Goodrich & Rosati advised Arcellx on the transaction.
Client Highlights
9.22.22
Wilson Sonsini Advises Aadi Bioscience, Inc. on $72.5 Million Private Placement Equity Financing
On September 22, 2022, Aadi Bioscience, Inc., a commercial-stage biopharmaceutical company focused on precision therapies for genetically-defined cancers with alterations in mTOR pathway genes, announced it has entered into a securities purchase agreement with a new accredited investor and certain existing investors to issue and sell an aggregate of 3,373,526 shares of its common stock at a price of $12.50 per share, reflecting the closing price on September 21, 2022 on NASDAQ, and pre-funded warrants to purchase up to an aggregate of 2,426,493 shares of common stock at a purchase price of $12.4999 per pre-funded warrant share, through a private investment in public equity (PIPE) financing. The Pre-Funded Warrants will have an exercise price of $0.0001 per share of common stock, to be immediately exercisable and remain exercisable until exercised in full. Aadi Bioscience anticipates the gross proceeds from the PIPE to be approximately $72.5 million, before deducting any offering related expenses. The financing is expected to close on September 26, 2022, subject to customary closing conditions.